[EN] METAL COMPLEXES HAVING DUAL HISTONE DEACETYLASE INHIBITORY AND DNA-BINDING ACTIVITY [FR] COMPLEXES MÉTALLIQUES AYANT UNE DOUBLE ACTIVITÉ INHIBITRICE D'HISTONE DÉSACÉTYLASE ET DE LIAISON À L'ADN
[EN] METAL COMPLEXES HAVING DUAL HISTONE DEACETYLASE INHIBITORY AND DNA-BINDING ACTIVITY [FR] COMPLEXES MÉTALLIQUES AYANT UNE DOUBLE ACTIVITÉ INHIBITRICE D'HISTONE DÉSACÉTYLASE ET DE LIAISON À L'ADN
A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity
作者:Darren Griffith、Maria P. Morgan、Celine J. Marmion
DOI:10.1039/b916715c
日期:——
The successful design and synthesis of a novel multifunctional platinum drug candidate with DNA binding, histone deacetylase inhibitory activity and enhanced selectivity for cancer cells are described.
METAL COMPLEXES HAVING DUAL HISTONE DEACETYLASE INHIBITORY AND DNA-BINDING ACTIVITY
申请人:Marmion Celine Josephine
公开号:US20120190874A1
公开(公告)日:2012-07-26
Compounds comprising a metal complex having the structure [X—Y—Z-M
n+
]
p+
.B are disclosed in which X is a histone deacetylase inhibitor, M
n+
is a DNA-binding heavy metal ion, Y is an aliphatic or aromatic spacer or is absent, and Z is a mono- or bi-dentate or chelating donor linker, or a bridging linker, P+ designates the charge on the complex ion, which may be positive, negative or absent and B is a counterion or is absent. The linker Z is labile and its metal complex X—Y—Z-M
n+
is capable of being hydrolysed in-vivo. The compounds find application in the treatment of cancer.
US8901337B2
申请人:——
公开号:US8901337B2
公开(公告)日:2014-12-02
[EN] METAL COMPLEXES HAVING DUAL HISTONE DEACETYLASE INHIBITORY AND DNA-BINDING ACTIVITY<br/>[FR] COMPLEXES MÉTALLIQUES AYANT UNE DOUBLE ACTIVITÉ INHIBITRICE D'HISTONE DÉSACÉTYLASE ET DE LIAISON À L'ADN